Rajasthan Suspends Use Of Common Anaesthesia Injection In Surgeries: What It Means For Patients
Last Updated:
This suspension has sparked concern among patients scheduled for surgeries, especially those requiring spinal or epidural anaesthesia.
Patients are advised to stay informed but not panic. Delaying essential surgeries could pose greater health risks than proceeding with safe alternatives under medical supervision.
The Rajasthan Drug Control Department has taken swift precautionary action by suspending the sale and use of a specific batch of Bupivacaine Hydrochloride in Dextrose injection, a widely used local anaesthetic. This move follows reports of serious adverse reactions in 16 patients in Hyderabad after receiving the injection from a particular batch manufactured by Themis Medicare Limited. Health authorities are prioritizing patient safety while investigations are underway.
This suspension has sparked concern among patients scheduled for surgeries, especially those requiring spinal or epidural anaesthesia. However, experts clarify that the ban applies only to one specific batch (BKP02601) and not to the drug itself. Hospitals across Rajasthan have already initiated recalls, and alternative anaesthesia options remain readily available.
Patients are advised to stay informed but not panic. Delaying essential surgeries could pose greater health risks than proceeding with safe alternatives under medical supervision.
What is Bupivacaine and Its Role in Surgeries
Bupivacaine is a popular long-acting local anaesthetic that numbs specific areas of the body by blocking nerve signals without causing unconsciousness. It is commonly used in cesarean sections, orthopaedic procedures, labour pain relief, dental surgeries, and post-operative pain management.
Why Was This Common Anaesthesia Batch Banned?
The Rajasthan Drug Controller acted after patients experienced severe symptoms such as nausea, vomiting, intense headaches, seizures, and in some cases, required ventilator support and ICU admission. The Indian Society of Anesthesiologists has also issued a nationwide advisory urging caution with Themis Medicare’s Bupivacaine injections.
What Patients Need To Know?
Do not cancel or postpone scheduled surgeries without consulting your doctor. Hospitals have switched to unaffected batches or alternative anaesthetics like lidocaine or ropivacaine. Discuss any concerns with your anaesthesiologist beforehand and inform them of any past allergies to anaesthetic drugs. (45 words)
Safety Measures and Ongoing Actions
Authorities have recalled thousands of injections from the affected batch across multiple districts. Samples are being tested in laboratories to identify the root cause. Patients who recently underwent procedures using this batch should monitor for symptoms like persistent headache, vomiting, confusion, or breathing difficulties and seek immediate medical help if they appear.
This incident highlights the importance of stringent drug quality control in India’s healthcare system. While such bans can cause temporary anxiety, they demonstrate proactive governance aimed at protecting public health. Patients are encouraged to trust their healthcare providers and focus on open communication regarding anaesthesia plans.
Medical professionals reassure that safe and effective alternatives are widely available, ensuring surgeries can proceed without compromising patient safety. Staying updated through official health channels remains the best approach during such situations.
